Metrics as of 10/13/2026, 06:55 PM (Berlin time), refresh in progress.
OptimizeRx Stock
OptimizeRx Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Stephen L. Silvestro
- Employees
- 133
- Market cap
- $158 M
- IPO
- 28/11/2007
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial…
OptimizeRx stock: price history
1D
+2.6%
1W
-4.3%
1M
+15.6%
6M
+39.3%
YTD
-31.2%
1Y
-55.0%
2Y
+27.1%
5Y
-89.4%
10Y
+160.2%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~11% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about OptimizeRx
Analyst assessment of OptimizeRx
PRICE TARGET LOW
US$7.00
CONSENSUS
US$10.25
MEDIAN
US$11.00
PRICE TARGET HIGH
US$12.00
0
STRONG BUY
11
BUY
4
HOLD
0
SELL
0
STRONG SELL
15
TOTAL · Buy
As of: 29/09/2026
OptimizeRx stock metrics
P/E
34.59
P/B
1.21
EV/EBITDA
9.75
RETURN ON EQUITY
-0.5%
NET MARGIN
-3.4%
DEBT/EQUITY
0.15
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
76.9%
FLOAT SHARES
14,426,777
AVG. DAILY VOLUME (30D)
160,101
Insider transactions (SEC)
D'Silva Andrew J.
D'Silva Andrew J.
Stelmakh Edward
D'Silva Andrew J.
Odence-Ford Marion
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about OptimizeRx stock
What does OptimizeRx do?
OptimizeRx Corp. is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Stephen L. Silvestro, the company employs around 133 people.
The IPO was on 28/11/2007; the stock trades on NASDAQ under the ticker OPRX.
What do analysts say about OptimizeRx stock?
15 analysts rate the stock, the consensus is Buy (as of 29/09/2026).
The average price target is US$10.25, ranging from US$7.00 to US$12.00, with a median of US$11.00.
This is an external assessment, not a statement by Market Jury.
When does OptimizeRx report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 11% stronger than usual.
Does OptimizeRx pay a dividend?
No, OptimizeRx currently does not pay a dividend.
Which stocks are comparable to OptimizeRx?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get OptimizeRx stock analyzed?
Clicking "Analyze stock" lets five strategies assess OptimizeRx against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.